You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: April 16, 2025

Drug Price Trends for NDC 30698-0459


✉ Email this page to a colleague

« Back to Dashboard


Best Wholesale Price for NDC 30698-0459

These are wholesale prices available to the US Federal Government which, by law, must be the best prices available under comparable terms and conditions
Drug NameVendorNDCCountPrice ($)Price/Unit ($)DatesPrice Type
LOPRESSOR 100MG TAB Validus Pharmaceuticals LLC 30698-0459-01 100 282.04 2.82040 2024-01-01 - 2028-03-31 FSS
LOPRESSOR 100MG TAB Validus Pharmaceuticals LLC 30698-0459-01 100 264.87 2.64870 2023-04-02 - 2028-03-31 FSS
LOPRESSOR 100MG TAB Validus Pharmaceuticals LLC 30698-0459-01 100 246.03 2.46030 2023-04-01 - 2028-03-31 FSS
>Drug Name>Vendor>NDC>Count>Price ($)>Price/Unit ($)>Dates>Price Type
Price type key: Federal Supply Schedule (FSS): generally available to all Federal Govt agencies / 'BIG4' prices: VA, DoD, Public Health & Coast Guard only / National Contracts (NC): Available to specific agencies
Showing 1 to 3 of 3 entries

Market Analysis and Price Projections for the Drug NDC: 30698-0459

While the specific NDC code 30698-0459 is not provided in the sources, we can still delve into the general principles of market analysis and price projections for pharmaceuticals, which can be applied to any drug with a similar NDC code.

Understanding NDC Codes

National Drug Codes (NDCs) are unique identifiers assigned to pharmaceutical products. Each NDC code consists of three segments: the labeler code, the product code, and the package code. Understanding these components is crucial for market analysis and pricing[5].

Market Analysis

Industry Trends

The pharmaceutical market, particularly the biopharma and biotech sectors, is experiencing rapid growth driven by technological advancements, evolving regulatory frameworks, and a shift towards patient-centered care. The biopharma market is projected to grow at a compound annual growth rate (CAGR) of 7.56% between 2024 and 2029, while the biotech sector is expected to grow at a CAGR of 9.4% between 2021 and 2027[3].

Competitive Landscape

In the context of non-small cell lung cancer (NSCLC), for example, targeted therapies are expected to drive significant market growth. Drugs like Tagrisso, Avastin, and Cyramza are projected to achieve substantial sales by 2025, with Tagrisso expected to reach $1.7 billion in sales at a CAGR of 56.6%[4].

Regulatory Environment

Regulatory compliance is critical for pharmaceutical companies. Manufacturers must report data on their covered outpatient drugs, including the Average Manufacturer Price (AMP), to comply with Medicaid requirements. This includes timely reporting of new NDCs to ensure compliance with other reporting responsibilities[2].

Price Projections

Pricing Factors

Several factors influence the pricing of pharmaceuticals:

  • Manufacturing Costs: The cost of production, including research and development expenses.
  • Market Demand: The demand for the drug, which can be influenced by the presence of competitors and the severity of the condition it treats.
  • Regulatory Environment: Pricing regulations and rebate requirements can significantly impact the final price of a drug.
  • Patent Status: Patent expirations can lead to the introduction of generics, which can reduce the price of the original drug[4].

Pricing Models

Pharmaceutical companies often use various pricing models, including:

  • List Price: The initial price set by the manufacturer.
  • Net Price: The price after discounts, rebates, and other adjustments.
  • Best Price: The lowest price available to any best price eligible entity, which is crucial for Medicaid rebates[2].

Example Pricing Analysis

For a drug like CLIMARA 0.06 MG/DAY PATCH (NDC 50419-0459), the price per unit can vary based on the vendor, count, and price type. For instance, the price per unit for CLIMARA 0.06 MG/DAY PATCH can range from $5.87 to $34.08 depending on the pricing type and vendor agreements[1].

Predictions for 2025

Accelerated Clinical Trials

Innovative clinical trial designs are expected to reshape drug development in 2025, leading to more efficient and patient-centered trials. This could impact the pricing of new drugs by reducing development costs and speeding up the time to market[3].

Precision Medicine

The rise of precision medicine, aided by AI and machine learning technologies, is expected to personalize healthcare further. This could lead to more targeted and effective treatments, potentially affecting the pricing strategy for drugs that offer significant clinical benefits[3].

Regulatory Evolution

The regulatory landscape is evolving to keep pace with innovation. This includes clearer guidelines on reporting new NDCs and compliance with pricing regulations, which will be crucial for maintaining market competitiveness[2].

Key Takeaways

  • NDC Codes: Understanding the components of NDC codes is essential for market analysis.
  • Industry Trends: The biopharma and biotech sectors are experiencing rapid growth driven by technological advancements and regulatory changes.
  • Pricing Factors: Manufacturing costs, market demand, regulatory environment, and patent status all influence drug pricing.
  • Pricing Models: List price, net price, and best price are critical in pharmaceutical pricing strategies.
  • Regulatory Compliance: Timely reporting of NDCs and compliance with pricing regulations are vital for market participation.

FAQs

What is the significance of NDC codes in pharmaceutical market analysis?

NDC codes are unique identifiers that help in tracking and analyzing specific drug products, ensuring accurate market data and compliance with regulatory requirements.

How do regulatory changes impact drug pricing?

Regulatory changes, such as those related to reporting Average Manufacturer Price (AMP) and best price, can significantly affect the final price of a drug by influencing rebates and discounts.

What role does precision medicine play in drug pricing?

Precision medicine can lead to more targeted and effective treatments, potentially justifying higher prices due to the significant clinical benefits offered.

How do patent expirations affect drug prices?

Patent expirations can lead to the introduction of generics, which typically reduce the price of the original branded drug.

What are the key factors influencing pharmaceutical pricing?

The key factors include manufacturing costs, market demand, regulatory environment, and patent status.

More… ↓

⤷  Try for Free

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.